Glycemic Control, Type II Diabetes, Parathyroidectomy

Running, not enrolling

Conditions studied: Primary Hyperparathyroidism, Type 2 Diabetes

In brief

The purpose of this study is to assess glycemic control after parathyroidectomy in patients with primary hyperparathyroidism and concomitant type 2 diabetes mellitus.

Key facts

Study ID

NCT05761743

Run by

The Cleveland Clinic

People needed

80

Starts

2023-02-27

Expected to finish

2026-08-01

Last updated by the study team

2026-05-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Study group: Consecutive patients older than 18 years old with concomitant PHPT and DM who will undergo PTX. The indications and need for surgery will be independent from the research team.
• Control group: Consecutive patients older than 18 years old with concomitant PHPT and DM who will not undergo PTX. The indications to forgo surgery will be independent from the research team.

You may not qualify if…

• Patients with recurrent or persistent PHPT will not be included.
• Patients who are included but have evidence of recurrent or persistent PHPT based on six-month laboratory workup will be excluded from the final analysis (<5% expected)9.
• Patients with type 1 diabetes mellitus
• Patients with secondary and/or tertiary hyperparathyroidism

Where it is running

• Cleveland Clinic Main Campus — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.